Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.

Revenue projections:

Revenue projections for CAPLIPOINT
Revenue projections for CAPLIPOINT



Financial Ratios:

currentRatio 8.172000
forwardPE 19.224325
debtToEquity 0.166000
earningsGrowth 0.183000
revenueGrowth 0.105000
grossMargins 0.592070
operatingMargins 0.319770
trailingEps 77.160000
forwardEps 0.000000

CAPLIPOINT's current ratio being 8.172 suggests that it has more than enough liquidity to cover short-term debt obligations. The company's cash reserves and current assets are sufficient to meet immediate liabilities, signaling solid financial health and minimal risk.
CAPLIPOINT's Forward PE is in an attractive range, meaning its stock price aligns well with earnings and isn't inflated. This creates room for growth, making it a solid investment opportunity for those looking to benefit from potential price appreciation.
With positive growth in both earnings and revenue, CAPLIPOINT is expected to grow its business. These indicators highlight a strong financial outlook, with the company on track for continued expansion and increasing profitability.
CAPLIPOINT's positive gross and operating margins reflect strong profitability and operational efficiency. These metrics indicate the company's ability to control costs while maintaining healthy revenue, contributing to its solid financial performance.

Price projections:

Price projections for CAPLIPOINT
Price projections for CAPLIPOINT

CAPLIPOINT's present price, in comparison to its projections, indicates no evident risks or opportunities. This balanced scenario suggests a steady environment, where investors might choose to wait for more definitive indicators before altering their strategies.

Recommendation changes over time:

Recommendations trend for CAPLIPOINT
Recommendations trend for CAPLIPOINT


A recent buy bias from analysts toward CAPLIPOINT may inspire confidence in investors, who could view the stock as a promising investment. This positive sentiment suggests that CAPLIPOINT might be an appealing option for those looking to grow their wealth through stock market investments.